Analysis and Reflections on the Differences in Quality Regulation of Drug Clinical Trials Between Domestic and International Practices

Li Xiaojuan, Tian Lijuan

Chinese Pharmaceutical Affairs ›› 2026, Vol. 40 ›› Issue (2) : 141-147.

PDF(993 KB)
PDF(993 KB)
Chinese Pharmaceutical Affairs ›› 2026, Vol. 40 ›› Issue (2) : 141-147. DOI: 10.16153/j.1002-7777.2025-07-0005
Supervision & Administration

Analysis and Reflections on the Differences in Quality Regulation of Drug Clinical Trials Between Domestic and International Practices

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 40(2): 141-147 https://doi.org/10.16153/j.1002-7777.2025-07-0005

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(993 KB)

Accesses

Citation

Detail

Sections
Recommended

/